Silicon Angle
by Mike Wheatley
April 8, 2019
Nvidia Corp. reckons artificial intelligence has evolved to the point where it can be reliably used to help diagnose diseases and discover new drugs.
To enable these new capabilities, the maker of graphics processing unit chips and computers, today announced it’s collaborating with two groups, including the American College of Radiology on an open AI architecture and reference implementation, and the Accelerating Therapeutics for Opportunities in Medicine consortium on a new supercomputer platform...
